Most periods are not a medical problem. The problem is what happens when symptoms that do disrupt someone’s life are waved away as “just part of being a woman”, by families, workplaces and sometimes clinicians.
In a 2023 national survey of more than 3,500 Australian women aged 18 to 44, nearly 4 in 5 reported painful, heavy or irregular periods. Of those, 3 in 4 said it made daily activities harder, and 2 in 5 had missed work or study because of it (Jean Hailes for Women’s Health, 2025). That was a survey, not a clinical study, but symptoms on that scale deserve to be investigated, not normalised.
The conditions below show what dismissal costs: they are common, and too often slow to be recognised and diagnosed.
Endometriosis
Around 1 in 7 Australian women are diagnosed with endometriosis by their late 40s, and many spend years in pain before anyone names it.
PMOS (formerly PCOS)
Around 1 in 8 women live with PMOS, a hormonal and metabolic condition that spent decades misnamed after ovarian cysts most people with it don't have.
PMDD
Premenstrual dysphoric disorder is a severe mood condition that arrives with the menstrual cycle. It was only fully recognised in 2013, and there is no published national estimate of how many Australians live with it.
Periods & pain
Period pain is common, and heavy bleeding affects about 1 in 4. When they disrupt daily life they deserve a proper check, yet women's pain is often dismissed.
Menopause & perimenopause
Menopause happens to every woman who reaches midlife, and symptoms can last 5 to 10 years. In 2024 a Senate inquiry called for better training, research and workplace support.
When the pill becomes the default
A revolution, then a default. Since it arrived in 1961, the pill has transformed women’s lives, giving them reliable control over whether and when to have children. It is safe and effective for most women who use it. The issue is not the pill itself. It is how often it becomes the first answer to symptoms nobody has investigated, how late some of its effects were studied, and how contraception became women’s job by default.
Prescribed for more than contraception
Pills that combine cyproterone with ethinyloestradiol (such as Diane-35 and its generics) are approved for moderate to severe acne and excess hair growth linked to androgens (hormones such as testosterone), and they also work as contraceptives. Europe’s medicines regulator found their risk of blood clots in the veins is about 1.5 to 2 times that of standard combined pills containing levonorgestrel. It described the risk as low and rare, and concluded the benefits outweigh the risks when they are used as approved, for acne only after other treatments have failed (European Medicines Agency, 2013). Australia’s regulator, the TGA, also keeps them available for their approved uses (TGA safety alert). France’s regulator disagreed: it concluded the risks outweighed the benefits for acne and suspended them there (European Medicines Agency, 2013). That review also found the pills were widely used off-label (for a use they are not approved for), as a contraceptive alone.
Pain can be masked
If the pill keeps period pain under control, endometriosis may only be diagnosed when a woman stops taking it. University of Melbourne researchers describe this as a paradox, because endometriosis is also thought to be less likely to progress while a woman is on the pill, although the evidence for that is limited (The Conversation, 2017).
Symptoms managed before they are explained
In a UK study, 32 women attending a pelvic pain clinic described how their symptoms were normalised, by themselves and by their family doctors, and suppressed with hormones before anyone reached a diagnosis (Ballard et al., Fertility and Sterility, 2006). It was a small interview study, so it shows what those experiences are like rather than how common they are.
Mood effects, studied late
A Danish study followed more than 1 million women and adolescents aged 15 to 34. Those using hormonal contraception were more likely to start an antidepressant for the first time than non-users: about 1.2 times as likely for combined pills, and about 1.8 times for adolescents aged 15 to 19 on combined pills. The pattern for first diagnoses of depression was similar or slightly weaker (Skovlund et al., JAMA Psychiatry, 2016). This is an association, not proof that hormonal contraception causes depression. It was published in 2016, more than 50 years after the pill arrived.
Why don’t men take a pill?
The contraceptive methods men can use today are condoms, vasectomy and withdrawal; the newest of them, the condom, reached the market more than 200 years ago (Page, Blithe and Wang, Frontiers in Endocrinology, 2022). In a trial of hormone injections for men, published in 2016, the method worked for about 96% of continuing users. Recruitment was stopped early on the advice of an external safety review committee, after side effects including depression and other mood changes, yet more than 75% of the men taking part said they would be willing to use it (Endocrine Society, 2016).
That is not simply a story of men refusing side effects that women accept. Women weigh the risks of contraception against the risks of pregnancy itself, which men do not carry, so the trade-off is genuinely different.
The deeper reason is investment. Pharmaceutical companies have largely abandoned male contraceptive development, leaving the work mainly to public funders such as the US National Institutes of Health and to non-profits, and researchers say progress has been held back by “a paucity of monetary investment” (Page, Blithe and Wang, Frontiers in Endocrinology, 2022). New options are being tested. In an NIH-funded trial of a daily hormonal gel, 86% of 222 men reached the target level of sperm suppression by week 15; these are interim results from a trial that is still running (Endocrine Society, 2024). A hormone-free pill, YCT-529, has entered human trials (ClinicalTrials.gov NCT06094283).
Contraception became women’s responsibility by default, and the investment to share it never followed.
Talk to a doctor before starting, changing or stopping any medication.